Metraipolis › archive › dc_bbf494c9a9bc

Long-term safety and effectiveness of romiplostim in patients with refractory aplastic anemia: a nationwide, all-case, post-marketing surveillance study in… — Europe PMC PMID:42223664

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42223664
DOI
10.1007/s00277-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-01T03:08:54.067Z
SHA-256 of the archived text
199d4f6a611744ee2917cd94a5048466bf15da6c9bfd5bb8d629462a7714c947
Stable URL of this page
https://metraipolis.com/documento/dc_bbf494c9a9bc

How to cite

Long-term safety and effectiveness of romiplostim in patients with refractory aplastic anemia: a nationwide, all-case, post-marketing surveillance study in… — Europe PMC PMID:42223664 — Europe PMC (en), https://europepmc.org/article/MED/42223664 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbf494c9a9bc (Metraipolis archive dc_bbf494c9a9bc, sha256 199d4f6a611744ee2917cd94a5048466bf15da6c9bfd5bb8d629462a7714c947)
BibTeX
@misc{dcbbf494c9a9bc,
  title = {Long-term safety and effectiveness of romiplostim in patients with refractory aplastic anemia: a nationwide, all-case, post-marketing surveillance study in… — Europe PMC PMID:42223664},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42223664},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbf494c9a9bc; sha256 199d4f6a611744ee2917cd94a5048466bf15da6c9bfd5bb8d629462a7714c947},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42223664. Agents can read the archived copy with the MCP tool read_document.